Rome Therapeutics has a total of 8 patents globally. Of these 8 patents, all the patents are active. The United States of America is where Rome Therapeutics has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Rome Therapeutics.
Rome Therapeutics was founded in 2017. Rome Therapeutics is a biotech company. The company offers research and testing services and focuses in generating human DNA immune health treatments for immune-related diseases and cancer.
Do read about some of the most popular patents of Rome Therapeutics which have been covered by us in this article and also you can find Rome Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Rome Therapeutics patent portfolio.
How many patents does Rome Therapeutics have?
Rome Therapeutics has a total of 8 patents globally. These patents belong to 7 unique patent family. Out of 8 patents, all the patents are active.
How Many Patents did Rome Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Rome Therapeutics Applications Filed | Rome Therapeutics Patents Granted |
| 2023 | 5 | – |
| 2022 | 3 | – |
How many Rome Therapeutics patents are Alive/Dead?
All the Rome Therapeutics patents are alive.
How Many Patents did Rome Therapeutics File in Different Countries?
Rome Therapeutics filled all their patents in United States of America.
Where are Research Centers of Rome Therapeutics Patents Located?
The Research Center of Rome Therapeutics Patents is the United States of America.
List of Rome Therapeutics Patents
| Rome Therapeutics Patent | Title |
| US20230295212A1 | Compounds And Methods For Treating Disease |
| WO2023178127A1 | Methods Of Treating Medical Conditions Using Stampidine Or A Related Compound |
| WO2023178133A1 | Compounds And Methods For Treating Disease |
| WO2023178128A1 | Methods Of Treating Medical Conditions Using Islatravir Or A Related Compound |
| WO2023164472A1 | Methods Of Treating Medical Conditions Using Censavudine Or A Related Compound |
| WO2022271878A1 | 4-Ethynyl-3-Hydroxy-Tetrahydrofuranyl-Adenine Phosphoramidates And Related Compounds And Their Use In Treating Medical Conditions |
| WO2022271880A1 | Methods Of Treating Medical Conditions And Inhibiting Line1 Reverse Transcriptase Using A Substituted Adeninyl-Propyloxy Phosphonic Acid Or Related Compound |
| WO2022245814A1 | Methods Of Treating Medical Conditions And Inhibiting Line1 Reverse Transcriptase Using A Substituted 4-Fluoro-2,5-Dihydrofuranyl Phosphonic Acid Or Related Compound |
What are Rome Therapeutics key innovation segments?
What Technologies are Covered by Rome Therapeutics?
The chart below distributes patents filed by Rome Therapeutics